Evidence map›Paper›PMID 35880400›Full record

GuidelineBiomolecules & biomedicine2023

Guidelines for breast cancer management in Bosnia and Herzegovina.

Lejla Hadžikadić-Gušić, Timur Cerić, Inga Marijanović, Ermina Iljazović, Dijana Koprić, Anela Zorlak, Mahira Tanović, Alma Mekić-Abazović, Ibrahim Šišić, Una Delić and 4 more

Abstract readGuideline
In one paragraph

Guideline in Biomolecules & biomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lejla Hadžikadić-GušićDepartment of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Timur CerićDepartment of Medical Oncology, University Clinical Center, Sarajevo, BiH.
Inga MarijanovićDepartment of Medical Oncology, University Clinical Center, Mostar, BiH.
Ermina IljazovićDepartment of Pathology, University Clinical Center, Tuzla, BiH.
Dijana KoprićDepartment of Pathology, University Clinical Center, Tuzla, BiH.
Anela ZorlakGenetics Counseling, Genetika, Sarajevo, BiH.
Mahira TanovićDepartment of Plastic and Reconstructive Surgery, Advanced Plastic Surgery of North Shore, NY, USA.
Alma Mekić-AbazovićDepartment of Medical Oncology, Kanton Hospital Zenica, Zenica, BiH.
Ibrahim ŠišićDepartment of Medical Oncology, Kanton Hospital Zenica, Zenica, BiH.
Una DelićDepartment of Medical Oncology, University Clinical Center, Sarajevo, BiH.
Jasminka Mustedanagić-MujanovićDepartment of Pathology, University Clinical Center, Tuzla, BiH.
Alija AginčićDepartment of Plastic and Reconstructive Surgery, Our Little Clinic, Sarajevo, BiH.
Edin BećiragićDepartment of Surgery, Dr. Abdulah Nakas General Hospital, Sarajevo, BiH.
Frederick GreeneDepartment of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common cancer among women. In Bosnia and Herzegovina, accurate data on the status of breast cancer are lacking due to the absence of a central registry. Multiple international guidelines imply that institutions that monitor breast cancer patients should have optimal therapeutic options for treatment. In addition, there have been several international consensus guidelines written on the management of breast cancer. Application of consensus guidelines has previously been demonstrated to have a positive influence on breast cancer care. The importance of specialty breast centers has previously been reported. As part of the 2021 Bosnian-Herzegovinian American Academy of Arts and Sciences (BHAAAS) conference in Mostar, a round table of multidisciplinary specialists from Bosnia and Herzegovina and the diaspora was held. All were either members of BHAAAS or regularly participate in collaborative projects. The focus of the consortium was to write the first multidisciplinary guidelines for the general management of breast cancer in Bosnia and Herzegovina. Guidelines were developed for each area of breast cancer treatment and management. These guidelines will serve as a resource for practitioners managing breast cancer in the Bosnia and Herzegovina region. This might also be of benefit to the ministry of health and any future investors interested in developing breast cancer care policies in this region of the world.

Indexed as

Breast NeoplasmsMedicineAcademies and InstitutesBosnia and HerzegovinaFemaleHumansInterdisciplinary StudiesUnited States

Identifiers

PMID35880400
PMCPMC9901905

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.